Zobrazeno 1 - 10
of 94
pro vyhledávání: '"Kei, Kushitani"'
Autor:
Hiroki Egusa, Takeshi Masuda, Kakuhiro Yamaguchi, Shinjiro Sakamoto, Yasushi Horimasu, Kei Kushitani, Taku Nakashima, Hiroshi Iwamoto, Hironobu Hamada, Noboru Hattori
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 1115-1123 (2024)
Introduction: There have been only a few cases showing the efficacy of pembrolizumab on granulocyte-colony-stimulating factor (G-CSF)-producing non-small-cell lung cancer (NSCLC) with high programmed cell death ligand 1 (PD-L1) expression. Herein, we
Externí odkaz:
https://doaj.org/article/822bb120aff24433ab027f1ee1685d00
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background The prognostic impact of EGFR mutation as major targetable somatic gene variant on lung adenocarcinoma is controversial. KRAS is another major somatic variant in lung adenocarcinoma, and a therapeutic agent for KRAS G12C became av
Externí odkaz:
https://doaj.org/article/6479d0a9753f4934a6f9fa62e911d4bd
Autor:
Atsushi Kagimoto, Yasuhiro Tsutani, Kei Kushitani, Takahiro Kambara, Takahiro Mimae, Yoshihiro Miyata, Yukio Takeshima, Morihito Okada
Publikováno v:
Thoracic Cancer, Vol 14, Iss 4, Pp 381-388 (2023)
Abstract Background The S100 calcium‐binding protein A4 (S100A4) and the accumulation of [18F]‐fluoro‐2‐deoxy‐D‐glucose (FDG) in noncancerous interstitial pneumonia (IP) area are predictors of postoperative acute exacerbation (AE) of IP a
Externí odkaz:
https://doaj.org/article/f7bccb167c6c43f68e4fe08ef387262a
Autor:
Masaoki Ito, Yoshihiro Miyata, Kei Kushitani, Atsushi Kagimoto, Daisuke Ueda, Yasuhiro Tsutani, Yukio Takeshima, Morihito Okada
Publikováno v:
Thoracic Cancer, Vol 12, Iss 23, Pp 3141-3149 (2021)
Abstract Introduction Tumor size is an absolute recurrence risk in lung cancer. Although morphological features also reflect recurrence risk, its significance among lower‐risk cases characterized by small size is unknown. We aimed to evaluate the r
Externí odkaz:
https://doaj.org/article/661e0f51c8a84c069ea1cc18bd0b1629
Autor:
Atsushi Kagimoto, Yasuhiro Tsutani, Kei Kushitani, Takahiro Kambara, Takahiro Mimae, Yoshihiro Miyata, Yukio Takeshima, Morihito Okada
Publikováno v:
BMC Pulmonary Medicine, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Acute exacerbation (AE) of interstitial pneumonia (IP) is the most fatal complication after lung resection for lung cancer. To improve the prognosis of lung cancer with IP, the risk factors of AE of IP after lung resection should
Externí odkaz:
https://doaj.org/article/0ac4c3035c654d2bb1965658e40e21c9
Autor:
Nozomi Karakuchi, Senichiro Yanagawa, Kei Kushitani, Shinya Kodama, Yukio Takeshima, Kazuo Sumimoto
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 1, Pp 538-544 (2021)
Sarcomatoid carcinoma (SC) is a rare malignant tumor with properties of both epithelial and mesenchymal carcinomas. SC has been reported in various organs, but the number of reports for each type is small. Small intestinal tumors make up about 3–6%
Externí odkaz:
https://doaj.org/article/3691f4a81277496485f6afa74e602297
Autor:
Kimitaka Makidono, Yoshihiro Miyata, Takuhiro Ikeda, Yasuhiro Tsutani, Yuichiro Kai, Kei Kushitani, Yukio Takeshima, Morihito Okada
Publikováno v:
Journal of Medical Case Reports, Vol 15, Iss 1, Pp 1-4 (2021)
Abstract Background Bronchial fistula is a severe complication of pneumonectomy with a high mortality rate. We previously reported a technique for bronchial closure to prevent bronchial fistula in a canine model. We described that mucosal ablation co
Externí odkaz:
https://doaj.org/article/b9df61f014a7439984edd24590e74dc0
Autor:
Ihiro Endo, Vishwa Jeet Amatya, Kei Kushitani, Takahiro Kambara, Tetsuya Nakagiri, Yutaro Fujii, Yukio Takeshima
Publikováno v:
Frontiers in Oncology, Vol 11 (2022)
Malignant mesothelioma is a tumor with a poor prognosis, mainly caused by asbestos exposure and with no adequate treatment yet. To develop future therapeutic targets, we analyzed the microarray dataset GSE 29370 of malignant mesothelioma and reactive
Externí odkaz:
https://doaj.org/article/3f23dbe99c934e4caaabc215b12f2d82
Autor:
Atsushi Kagimoto, MD, Yasuhiro Tsutani, MD, PhD, Takahiro Kambara, MD, Yoshinori Handa, MD, PhD, Takashi Kumada, MD, Takahiro Mimae, MD, PhD, Kei Kushitani, MD, PhD, Yoshihiro Miyata, MD, PhD, Yukio Takeshima, MD, PhD, Morihito Okada, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 2, Pp 100126- (2021)
Introduction: The International Association for the Study of Lung Cancer proposed a new grading criteria for invasive adenocarcinoma. However, its utility has not been validated. Methods: Patients who underwent complete resection of lung adenocarcino
Externí odkaz:
https://doaj.org/article/f0d932583f84479ea7960e7a951bb131
Publikováno v:
Pathobiology. :1-11
Introduction: Malignant mesothelioma is an aggressive cancer associated with asbestos exposure. Currently, the efficacy of therapeutics is limited in malignant mesothelioma, and developing more effective therapies is the need of the hour. Non-coding
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a4b694cbfd302ba08aaddf7741481e1
https://doi.org/10.1159/000528670
https://doi.org/10.1159/000528670